The struggle to control infectious diseases has become increasingly difficult due to resistance to current antibiotics and the co-existence of multiplying and non-multiplying bacteria, which makes it an urgent task to discover new antibiotic targets and to develop new antibiotics. Hydrogenases are found in micro-organisms belonging to the archaea and bacteria domains, which can catalyse the reversible oxidation of hydrogen gas (H 2 ↔2H + + 2e) and play pleiotropic roles in microbial survival. Studies have shown that H 2 is a potent antioxidant and can selectively neutralize OH
INTRODUCTION
Since Alexander Fleming discovered the antibacterial property of penicillin in 1929, large numbers of antibiotics have been developed, making an important contribution to human health in the fight against infectious diseases. Accumulating knowledge on bacterial pathogenesis and antibiotic resistance has helped to develop many antibiotics. Currently known mechanisms of antibiotic resistance include modification of drug targets, reduction in antibiotic influx, export of antibiotics by efflux pumps and inactivation of antibiotics by specific enzymes [1] . In 2010, Kumarasamy et al. [2] reported that the 'superbugs' which produce NDM-1 (New Delhi metallo-β-lactamase) were resistant to almost all antibiotics, except for polymyxin and tigecycline. Actually, 'superbugs' have been found throughout the world, including Europe, Asia, Oceania and America. According to past experience, it is foreseeable that NDM-1 will be found in more areas in the near future.
The antibiotics currently available in clinical practice, which were discovered between the 1940s to 1980s, can only inhibit or kill exponentially growing bacteria. However, multiplying bacteria and non-multiplying bacteria co-exist in clinical infections [3] . Existing antibiotics can kill multiplying bacteria, but they are very inefficient in killing non-multipliers [3] . Therefore these metabolically inactive organisms can survive high concentrations of antibiotics [4] . When the drug concentration falls below the levels for killing or inhibiting the growing cells, nonmultipliers can reactivate and become multipliers, and the host will become reinfected and the disease returns [4] . This may explain the persistence of an infection in the host for a prolonged period of time and why bacterial diseases recur frequently.
The factors described above are some of the reasons for causing the failure of treatment of infectious diseases. The aims of the present Hypothesis article are to describe the mechanism of cell death induced by bactericidal antibiotics and the innate immune system, to surmise how bacteria avoid death induced by OH
• (hydroxyl radicals), and to introduce the therapeutic role of H 2 (hydrogen gas). We also describe the hydrogenases found in bacteria. Finally, we discuss the possible role of hydrogenases and H 2 in pathogenesis and antibiotic resistance, and speculate that hydrogenases might be a new molecular target for antibiotic discovery.
A COMMON PATHWAY
Apart from the already known antibiotic-resistance mechanisms, are there any other possible mechanisms we have not found yet? Answering such a question requires a better understanding of how antibiotics kill bacteria.
Collins and co-workers [5] have demonstrated that the three major classes of bactericidal antibiotics, regardless of drug-target interaction, all stimulate the production of highly deleterious OH • in Gram-negative and Gram-positive bacteria, which ultimately contributes to cell death. This OH
• -mediated cell death involves alterations in the TCA (tricarboxylic acid) cycle and hyperactivation of the ETC (electron transport chain) [6] . Oxidative-damage-mediated bacterial clearance is also a pivotal mechanism whereby the innate immune system combats infections. When bacteria are engulfed by professional phagocytes, such as macrophages, O 2 − (superoxide anion) will be generated by NADPH oxidase [7] . O 2 − destroys iron-sulfur clusters, making ferrous iron available for oxidation by the Fenton reaction, leading to OH
• formation, and OH • in turn damages DNA, proteins and lipids, resulting in cell death [8] . Therefore we conclude that OH
• -mediated bacterial death is a common pathway, which is important for both antibiotics and the innate immune system in combating invading micro-organisms ( Figure 1 ).
HOW WOULD BACTERIA REACT?
This OH
• -mediated pathway involves antibiotics and its targets, oxygen, the TCA cycle and OH
• . Thus, theoretically, bacteria may acquire antibiotic resistance in three ways. First, bacteria can employ existing resistance mechanisms, such as multi-drug efflux pumps, to inhibit the interaction between antibiotics and their targets, whereby bacteria reduce the formation of OH • by changing their metabolic state, living in the biofilm or using anaerobic respiration instead of aerobic respiration. Thirdly, bacteria can reduce O 2 − and H 2 O 2 production by SOD (superoxide dismutase) and catalase, thus reducing the formation of OH
• indirectly. Finally, bacteria may eliminate OH
• directly, although the mechanism for this remains unknown.
Shortly after bacterium uptake, the phagosome undergoes a series of transformations resulting from its sequential interaction with subcompartments of the endocytic pathway [7] . V-ATPases (H + -translocating ATPases) acidify the phagosomal lumen by translocating H + across the bilayer [7] . Phagosomal acidification creates a harsh environment that impedes microbial growth. Meanwhile, OH
• is generated in the phagosomes. These events may force bacteria to develop adaptive strategies to resist the high acidic environment. In addition, bacteria may also utilize substances to scavenge OH
• directly. We speculate that bacteria may survive hostile circumstances by avoiding aerobic respiration (such as changing to fermentation) and by scavenging OH
• directly. Thus the question is what kind of bacterial metabolite has the ability to eliminate OH
• ?
H 2 NEUTRALIZES OH • SELECTIVELY
Ohsawa et al. [9] have reported that the inhalation of H 2 markedly suppresses brain injury by selectively reducing OH • , the most cytotoxic ROS (reactive oxygen species). The most impressive thing is that the selective scavenging of OH
• by H 2 was performed in in vitro experiments, implying that the property of H 2 as a selective antioxidant has universal significance. Since the publication of that paper, experiments have been conducted to verify the mechanism of H 2 as a selective antioxidant. Over the last 4 years, it has been documented that H 2 can be used as a therapeutic gas in a number of disease models, such as intestinal ischaemia/reperfusion injury [10] , neonatal hypoxic brain injury [11] , myocardial ischaemia/reperfusion [12] and experimental liver injury [13] . In addition, Itoh et al. [14] have confirmed that H 2 attenuated type I allergy [15] . Most hydrogenases are found in micro-organisms belonging to the archaea and bacteria domains of life [15] . Table 1 shows a list of pathogens that contain hydrogenases. The [Fe]-hydrogenases, being restricted to some methanogens, are not discussed in the present paper. Taking Escherichia coli as an illustration, this bacterium contains four hydrogenases: Hya, Hyb, Hyc and Hyf [16] . Hyf, however, is a putative enzyme and its expression is very weak [17] . Hyc forms part of the FHL (formate hydrogenlyase) complex that catalyses the disproportionation of formate into CO 2 and H 2 [16] . Optimal expression of the hyc operons requires anaerobiosis and an acidic pH. Hya and Hyb perform respiratory H 2 oxidation linked to quinone reduction; Other physiological functions of bacteria, which are involved in bacterial virulence or antibiotic-resistance, include the use of PMF as an energy source. they link the oxidation of H 2 to the reduction of anaerobic electron acceptors with recovery of energy in the form of a PMF (proton motive force) [15] . Therefore H 2 metabolism and energy metabolism are closely linked.
PLEIOTROPIC EFFECTS
Since hydrogenases and H 2 play a crucial role in microbial energy metabolism, we speculate that hydrogenases and H 2 may exert pleiotropic effects on the pathogenesis and antibiotic resistance of bacteria ( Figure 2 ).
Neutralizing OH
• A lethal concentration of bactericidal treatment will induce bacterial death via OH • [5] . Thus endogenous or exogenous H 2 can reduce the killing effect by neutralizing cytotoxic OH
• . Non-multiplying and multiplying bacteria co-exist in a clinical infection and can quickly switch between different phases [4] , and nonmultiplying persisters can survive antibiotic therapy [18] . These persisters, such as E. coli, may produce H 2 owing to their low metabolic activity (e.g. anaerobic respiration). H 2 produced by these non-multiplying bacteria can effectively reduce the susceptibility of bacteria to antibiotics and facilitate antibiotic resistance. Thus, apart from indole [19] , H 2 can also enhance the survival of the overall population in stressful environments, leading to population-wide resistance.
Professional phagocytes, such as macrophages, are capable of ingesting and destroying invading organisms. The first microbicidal activity that any microbe will encounter is the O 2 − burst, which is generated by the NADPH complex [20, 21] [9] . Thus hydrogenase-containing micro-organisms will survive because H 2 can eliminate OH
• . For example, Sato and co-workers [22] have shown that the generation of H 2 and the reduction of oxidative stress are important for the survival of Klebsiella pneumoniae in the oral cavity.
Providing energy
The pathogenic Helicobacter species H. pylori and H. hepaticus can respire H 2 through a respiratory [NiFe]-hydrogenase that has a high affinity for H 2 [15] , whereas a mutant hydrogenase strain of H. pylori is much less efficient in its colonization of mice [23] . In the case of H. hepaticus, a causative agent of chronic hepatitis and hepatocellular carcinoma in mice, mutants with the hyaB gene inactivated are deficient in H 2 -supported amino acid uptake and in causing liver lesions in mice [24] . The importance of H 2 to bacteria for growth in a mammalian host makes [NiFe]-hydrogenases a virulence factor. Thus, as for hydrogenase-containing pathogenic bacteria, H 2 is perhaps a good energy source, either produced endogenously or exogenously. Mycobacterium tuberculosis, one of the most important human pathogens, can exist in the human body for a relatively long time. Approximately 13 litres of H 2 are generated daily by intestinal bacteria via fermentation, and a portion of the gas is absorbed into the circulation and expelled with exhaled breath [25] . M. tuberculosis may survive by consuming H 2 from the large intestine. An inhibitor of hydrogenases, however, may play a role in eliminating the dormant M. tuberculosis by limiting energy availability.
Many chronic infections are associated with the ability of the pathogen to form a biofilm [26] . Klemm and coworkers [27] have used DNA microarray technology to examine the global gene expression profile of E. coli during sessile growth compared with planktonic growth, and found that three hydrogenase genes (hya, hyb and hyc) were significantly up-regulated during biofilm growth as opposed to all forms of planktonic growth. We speculate that the reason for the up-regulation of hydrogenase genes observed is associated with the energy provided by H 2 . However, whether hydrogenases play a role in biofilm formation and if inhibition of hydrogenases can control the formation of the biofilm are still unclear.
Maintaining acid-base homoeostasis
All microbes have evolved to grow within a particular range of external pH. Because H 2 production involves the consumption of 2H + , hydrogenase expression is likely to involve a pH response and homoeostasis. Hayes et al. [28] have observed that each hydrogenase operon in E.coli had a higher expression in acid than in base under O 2 limitation. More recently, Slonczewski and coworkers [29] have reported that Hyd-3 (hydrogenase-3) contributed to the anaerobic acid resistance of E. coli. Deletion of hyc decreased anoxic acid survival 3-fold at pH 2.5 and 20-fold at pH 2, and Hyc-dependent H 2 production increased 70-fold from pH 6.5 to 5.5. Thus we conclude that hydrogenases play an important role in maintaining acid-base homoeostasis in an anoxic acid environment.
After bacterial engulfment by macrophages, the VATPases acidify the phagosomal lumen and create a harsh environment, which inhibits microbial growth [7] . The V-ATPase also facilitates the generation of O 2 − by transporting H + in an unaccompanied manner, and the products of the oxidase can subsequently combine with H + in the lumen of the phagosome, generating more complex ROS, such as OH
• [7] . Therefore H 2 may facilitate bacterial survival and enhance their virulence by maintaining acid-base homoeostasis and neutralizing OH
• .
Other effects
Hydrogenases and H 2 play a central role in microbial energy metabolism, which is associated with the reduction of the quinone pool and the generation of PMF [15] . Several physiological functions of microorganisms use PMF as an energy source, such as the TAT (twin-arginine translocation) pathway [30] , multi-drug efflux pumps [31] and flagellar movement [32] . All of these are involved in bacterial virulence or antibiotic resistance. Thus it can be concluded that inhibitors of hydrogenases may enhance the killing effect against bacteria and relieve antibiotic resistance.
TESTING THE HYPOTHESIS
We speculate that hydrogenases and H 2 are involved in increasing bacterial antibiotic resistance and virulence.
To investigate this we propose to use an internationally sequenced strain and a clinical strain of E. coli as the experimental organism. Hyd-3, encoded by hyc gene, is the primary hydrogenase produced in E. coli and will be used. Deletion of hycE, encoding the large subunit of Hyd-3, will be undertaken to observe whether H 2 production is reduced both in the wild-type strains and hycE mutant strains. Then the complemented strains will be constructed to determine whether the function of the ΔhycE mutant strain can be partially or fully restored. Subsequently, phenotypic changes of these strains, including wide-type, hycE mutant and complemented strains, will also be determined. By comparing the MIC (minimal inhibitory concentration) values and survival rates in the presence of antibiotics, the ability of hydrogenases and H 2 to affect antibiotic resistance can be determined. Using these E. coli strains, an assessment of their pathogenicity can be determined by using a mouse pneumonia model. Collection of lungs and BALF (bronchoalveolar lavage fluid) and then culture of lung homogenates will enable the quantitative detection of bacteria and histological examination to be undertaken. Meanwhile, measurement of cytokines [TNF (tumour necrosis factor)-α, IL (interleukin)-6 and IL-8] in BALF by ELISA will enable the severity of the pneumonia and the role of hydrogenases in bacterial pathogenicity to be determined.
CONCLUSION AND FUTURE WORK
H 2 is a potent antioxidizing agent and can eliminate OH • selectively [9] . H 2 may neutralize OH • induced by antibiotics or produced by professional phagocytes, thus decreasing the killing effect of antibiotics and innate immunity. Hydrogenases, which are capable of producing H 2 , are expressed by bacteria in a low metabolic state. Inhibition of hydrogenases might enhance the killing effect of antibiotics and professional phagocytes. Meanwhile, H 2 and hydrogenases also regulate the adaptability of bacteria to the environment in other areas, as described above. Inhibition of hydrogenases in these areas may play a unique role in sterilization. The human body does not contain hydrogenases, so inhibition of hydrogenases should be safe in humans. Thus inhibition of hydrogenase activity and a reduction in H 2 production may be ideal anti-infection strategies.
In addition, Xia and co-workers [33] have reported that, apart from its antioxidant effects, H 2 also has antiapoptotic and anti-inflammatory effects. Whether bacteria can take advantage of these mechanisms to suppress innate immunity of hosts and acquire immunity for themselves need to be observed further. We believe that further study on hydrogenases and H 2 will lead to discovery of new pathogenic and antibiotic-resistance mechanisms of bacteria, and subsequently to the development of more effective anti-infective drugs in the near future.
